about
P184
Imaging biomarker roadmap for cancer studiesClassic models for dynamic contrast-enhanced MRI.Visualization of neural tissue water compartments using biexponential diffusion tensor MRI.MR microscopy of multicomponent diffusion in single neurons.MR microscopy of perfused brain slices.Cellular-interstitial water exchange and its effect on the determination of contrast agent concentration in vivo: dynamic contrast-enhanced MRI of human internal obturator muscle.Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix.Tracer kinetic analysis of dynamic contrast-enhanced MRI and CT bladder cancer data: A preliminary comparison to assess the magnitude of water exchange effects.Kidney volume to GFR ratio predicts functional improvement after revascularization in atheromatous renal artery stenosisGadofosveset-based biomarker of tissue albumin concentration: Technical validation in vitro and feasibility in vivo.Functional, anatomical, and molecular investigation of the cardiac conduction system and arrhythmogenic atrioventricular ring tissue in the rat heart.Imaging vascular physiology to monitor cancer treatment.Overcoming the low relaxivity of gadofosveset at high field with spin locking.Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives.Gadolinium-enhanced magnetic resonance imaging for renovascular disease and nephrogenic systemic fibrosis: critical review of the literature and UK experience.Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability.Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging.Estimating breast tumor blood flow during neoadjuvant chemotherapy using interleaved high temporal and high spatial resolution MRI.Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume.Sensitivity of quantitative myocardial dynamic contrast-enhanced MRI to saturation pulse efficiency, noise and t1 measurement error: Comparison of nonlinearity correction methods.Computer three-dimensional anatomical reconstruction of the human sinus node and a novel paranodal area.Perfusion estimated with rapid dynamic contrast-enhanced magnetic resonance imaging correlates inversely with vascular endothelial growth factor expression and pimonidazole staining in head-and-neck cancer: a pilot study.A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix.In vivo prostate magnetic resonance imaging and magnetic resonance spectroscopy at 3 Tesla using a transceive pelvic phased array coil: preliminary results.Multi-parametric MRI-guided focal tumor boost using HDR prostate brachytherapy: a feasibility study.BOLD imaging: a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular disease.Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancer.On the scope and interpretation of the Tofts models for DCE-MRI.Measurement of single kidney function using dynamic contrast-enhanced MRI: comparison of two models in human subjects.MR-derived renal morphology and renal function in patients with atherosclerotic renovascular disease.Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumors.Late tissue effects following radiotherapy and neoadjuvant hormone therapy of the prostate measured with quantitative magnetic resonance imaging.What levels of precision are achievable for quantification of perfusion and capillary permeability surface area product using ASL?In vivo dynamics and distribution of intracerebroventricularly administered gadodiamide, visualized by magnetic resonance imaging.Renal Cell Carcinoma Perfusion before and after Radiofrequency Ablation Measured with Dynamic Contrast Enhanced MRI: A Pilot Study.Tumour volume determination from MR images by morphological segmentation.Assessment of bladder motion for clinical radiotherapy practice using cine-magnetic resonance imaging.Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group.Establishment of the National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad) Biomarker Support Network.Organ-specific effects of oxygen and carbogen gas inhalation on tissue longitudinal relaxation times.
P50
Q30242020-63E8ED56-FFAD-4623-B6DE-3B8FF23B58E8Q30626277-A826A917-A536-4C33-B3A1-DA2DD6C0BDC0Q30644046-6B7AC3BD-6244-4351-8A37-1EE766BBBFEFQ30667050-079B9DF2-8B45-40C2-AE73-DD1B4D7BD048Q32174793-5005314F-9A3D-4579-ACB9-FAB3F12F422CQ33379841-080DC2E5-9AD8-41D5-A27F-AE07816E025EQ33620142-331EB802-4071-46F2-B4B9-B57380AF65DEQ33643193-5BDBBB5D-5346-4B92-B44A-20EB9D1CDCECQ33778192-5B094091-2A0D-4F66-8781-8C86287FB138Q34974971-F7BA2793-388B-4E5D-A49F-D3126C27E782Q35072208-E9153188-6028-4444-8702-1FFB9FFF41C0Q36357607-95BFAEDA-BE78-48A9-89B2-A9331E5B1D2CQ36882304-A46FE4B3-CE78-46D1-81A4-1D58D1D93FB2Q37232368-E9D26234-9E54-4B6E-AAE7-C9D7B2B7E112Q37420715-6886E6DE-3211-4D73-BA11-04994AAEF206Q37968863-7ACDB3D2-35D1-4238-B18F-7918CF3FB043Q38007857-48B10C84-99C3-4673-BD8C-EC21228C229AQ38859514-F78800A7-AE3F-4D8F-8E73-33C72C01A076Q40477780-9DDB9482-02CB-43AD-A3EE-784841778E80Q40970917-8325E349-D6CE-4C4D-897E-1A8636AE5A61Q43522285-691C56C1-EA7A-498A-BF22-38C9CE5F3EDEQ43608693-388BBEA0-56DC-4FBA-91AF-29DFBEE3A2DEQ44299287-7726D536-88E5-4E3D-B77E-179DFB483778Q44488177-21F36367-F09A-4F50-83CC-7E85A010E47BQ45014010-5286E73C-23D4-48B7-B288-52D630377701Q45116563-3E7C1BD0-2963-41E0-917C-7947E00FFC86Q46140795-CA4979BF-26E0-4260-92F7-6308AA831F68Q46265644-F1E6B5B5-302F-4887-81DB-F459EF5A152BQ47590624-9475FA0E-5547-4984-A5BD-F10697DAB437Q47604435-DFDE03B6-C07B-4FDB-97A7-5F16ACC2D829Q47641673-69141F38-D9DB-4AD7-B5D2-988C4107E71FQ47844587-FBDEA33B-E9D5-48E9-B2C2-2FDE42B76C74Q48094871-EB39636D-ED31-4921-B5C1-CEAB8914E209Q48226455-F33E6EB8-4721-449C-A630-B2BBF227F818Q48278209-D17686EE-D6BA-4865-885F-194946A72881Q48875186-FB0FF7BB-FCE8-4F2F-A0AF-061E13F5407EQ50592850-2E2FEBD2-0C3C-4E32-A7B9-86A39B6D3514Q50665913-EC99B1C8-515B-4BEA-8CDB-AA9C431473A0Q50710054-79174151-889A-4CFB-AF31-1AE5BCA8A505Q50922182-92825E0A-B985-41C9-938D-5BD384DCEC46
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
David Buckley
@ast
David Buckley
@br
David Buckley
@ca
David Buckley
@cs
David Buckley
@cy
David Buckley
@da
David Buckley
@de
David Buckley
@de-at
David Buckley
@de-ch
David Buckley
@en
type
label
David Buckley
@ast
David Buckley
@br
David Buckley
@ca
David Buckley
@cs
David Buckley
@cy
David Buckley
@da
David Buckley
@de
David Buckley
@de-at
David Buckley
@de-ch
David Buckley
@en
altLabel
David L Buckley
@br
David L Buckley
@ca
David L Buckley
@cs
David L Buckley
@cy
David L Buckley
@da
David L Buckley
@de
David L Buckley
@de-at
David L Buckley
@de-ch
David L Buckley
@en
David L Buckley
@en-ca
prefLabel
David Buckley
@ast
David Buckley
@br
David Buckley
@ca
David Buckley
@cs
David Buckley
@cy
David Buckley
@da
David Buckley
@de
David Buckley
@de-at
David Buckley
@de-ch
David Buckley
@en
P214
P244
P1053
L-8343-2017
P106
P185
P1960
jGIMhpIAAAAJ
P21
P213
0000 0001 1440 1698
P214
P244
n2003130766
P31
P3829
P496
0000-0001-6659-8365
P734
P735
P7859
lccn-n2003130766